Inovio Pharmaceuticals, Inc. Nasdaq Global Select
Open: $1.92 High: $1.95 Low: $1.85 Close: $1.92
Range: 2022-06-23 - 2022-06-24
Market: Closed
Inovio Pharmaceuticals, Inc. 6769 MESA RIDGE RD.
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
  • CEO: J. Joseph Kim
  • Employees: 317
  • Sector: Healthcare
  • Industry: Biotechnology
Latest Stocks Posts
Card image
Card image
Card image
INO News
Latest news about the INO